Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 235.16 million | USD 450.86 million | 7.5% | 2023 |
The global mobile biosafety laboratory market size was worth around USD 235.16 million in 2023 and is predicted to grow to around USD 450.86 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.50% between 2024 and 2032.
A mobile biosafety laboratory is a facility equipped to manage the collection, analysis, and research of biological samples across locations, especially in remote areas or regions that are not easily accessible. Mobile biosafety laboratories (MBLs) comprise larger mobile vehicles such as trailers that carry the necessary laboratory-oriented equipment to the desired location for biological testing, analysis, and research. These facilities function like normal laboratories as they are equipped with all essential technologies required for conducting the necessary procedures. MSBs act as emergency facilities for the control and management of infectious diseases and meet the essential requirements of areas such as ports that are traditionally away from conventional laboratories. They supplement the requirements of fixed laboratories. The growing number of infectious diseases especially since COVID-19 has helped the industry for mobile biosafety laboratories gain higher momentum. Other factors such as the increased need to deliver improved medical care in remote locations and rising investments in the construction of novel MBLs will help the industry flourish rapidly during the forecast period. However, since mobile biosafety laboratories are relatively a new concept, the industry will face growth challenges.
Growing cases of infectious and contagious diseases across the globe will fuel the market demand
The global mobile biosafety laboratory market is expected to grow due to the increasing number of cases of infectious and contagious diseases across the globe. The emergence of COVID-19 infection in 2019 led to the renewed acknowledgment of building a robust research and medical care ecosystem in remote parts of the world that did not have access to the offerings of a permanent biosafety laboratory facility. As per official statistics, countries such as Brazil, the US, Mexico, and Russia suffered the maximum number of casualties caused by COVID-19. While the infectious diseases are under control as of present times, COVID-19 continues to affect lives across the globe with a certain number of patients being regularly reported worldwide. In addition to this, the global population is plagued by several other forms of infectious diseases, and in some cases, the medical conditions can be fatal.
In April 2024, researchers claimed that the world is vulnerable to Disease X which is a form of Influenza and has the potential to become the next pandemic as per official reports. The World Health Organization (WHO) has claimed that humans have no immunity to the new flu strains and hence pose serious threats. Additionally, several existing infectious diseases have not found a permanent cure. Tuberculosis is known to impact over 1 million people worldwide. The rising population rate along with an increase in population density in urban areas elevates the risk of contagious diseases spreading at a faster rate thus leading to improvements in the testing and research facilities.
Growing demand for higher diagnostic and medical research centers in remote areas will trigger the market revenue rate
Mobile biosafety laboratories are expected to become highly popular across the globe due to the growing demand for robust medical research and diagnostic centers across the globe especially in remote parts of the world. In developed and emerging economies, people residing in remote locations do not have access to advanced medical care and disease diagnostic establishments. Such population groups continue to live with undiagnosed medical conditions leading to a lack of medical care and early fatality. As more efforts continue to be directed toward improving access to medical treatments in remote areas, the global mobile biosafety laboratory market will thrive.
High cost of investments and maintenance will restrict the market expansion rate
The global industry for mobile biosafety is expected to be restricted due to the high cost of initial investment required to construct such highly specialized and sophisticated facilities equipped with advanced medical research, diagnostics, and analysis tools. Furthermore, these units are customized to meet the needs of a mobile laboratory, unlike stationary centers that are generally built with prefabricated units. The cost of mobility further appreciates the overall cost involved in deploying mobile biosafety laboratories.
Increasing investments in MBL construction from governments will generate high-growth opportunities
The global mobile biosafety laboratory market is expected to generate high growth opportunities due to the increasing interest of the regional governments in exploring the concept and MBLs and investing in constructing robust centers. For instance, in February 2022, India witnessed the launch of its first biosafety level-3 mobile laboratory in the state of Maharashtra. The facility aimed to investigate emerging and reappearing highly infectious viral infections. In April 2023, Rapid Action Mobile BSL-3 Advanced Augmented Network (RAMBAAN) was showcased at the G-20 Health Working Group Meeting. It is Asia’s first mobile biosafety level-3 (BSL-3) laboratory and can access even the remotest parts of India. In June 2021, Italy-based Istituto Superiore di Sanità inaugurated a new mobile lab for biosafety purposes with an increased response capacity working against the rapidly spreading microorganisms deemed hazardous to the local community.
Rising launch of new technologies related to MBLs holds high growth potential
The industry for mobile biosafety laboratories is expected to be further promoted due to the increasing launch of new technologies that facilitate better execution of MBLs. For instance, increasing integration of Artificial Intelligence (AI) and miniaturization of research or diagnostic tools will be helpful in generating higher revenue during the forecast period. In February 2023, India’s Centre for Cellular and Molecular Platforms (C-CAMP) announced the launch of the National Diagnostics Catapult (C-CAMP InDx 2.0) that aims to encourage better preparedness in the country for existing or future pandemics that may impact the regional population thus potentially creating higher growth scope for the global mobile biosafety laboratory market.
Limited exposure to MBLs among potential consumer groups will challenge the market growth rate
The global industry for mobile biosafety laboratories is expected to be challenged due to limited exposure and awareness about the concept of mobile biosafety laboratories. Since the industry is relatively new, it is slowly gaining the attention of potential participants and may take a few years to deliver exceptional results. Moreover, the industry will be further impacted by the challenges associated with regulatory compliance.
The global mobile biosafety laboratory market is segmented based on application, type, and region.
Based on application, the global market segments are medical rescue, emergency disease, and others. In 2023, the highest demand was observed in the medical rescue segment due to an increase in the number of people infected by infectious diseases with cough and cold being the most common types of contagious infection reported worldwide. As per market reports, adults are prone to 2 to 4 colds annually. The growing efforts to curb and manage the spread of these infections will drive the segmental demand.
Based on type, the global market divisions are level 3, level 2, and level 1. In 2023, the highest growth was witnessed in the level 3 type of mobile biosafety laboratory. These centers are built to manage conditions that are mid to high risk to humans and follow stringent regulatory protocols established by official agencies such as the Centers for Disease Control & Prevention (CDC). Furthermore, they are equipped with advanced tools and systems to manage the conditions. The average cost of a level 3 MBL may be around USD 300,000.
Report Attributes | Report Details |
---|---|
Report Name | Mobile Biosafety Laboratory Market |
Market Size in 2023 | USD 235.16 Million |
Market Forecast in 2032 | USD 450.86 Million |
Growth Rate | CAGR of 7.50% |
Number of Pages | 232 |
Key Companies Covered | Mesa Labs, Bluestar BioTech, Microchem Laboratory, Bioneer, SanAir Technologies Laboratory, Hardy Diagnostics, IQuaTest, BiolabTech, Labconco, BSL Biosafety, Innohome, bioMérieux, BSL-3 Laboratory Solutions, MycoTech, Containment Solutions Inc., and others. |
Segments Covered | By Application, By Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America to continue leading the market growth rate as per projections
The global mobile biosafety laboratory market will be dominated by North America during the forecast period. The preliminary reason for the higher regional market growth rate is the mature existence of MBLs in countries such as the US and Canada. Following market research, the US is home to more than 200 biosafety labs at levels 3 and 4. The increasing number of patients with infectious conditions and the rising demand for primary medical care in remote parts of the nation will fuel regional revenue. These centers are highly regulated and compliance is a non-negotiable aspect of the region’s MSLs industry. Companies in North America continue to invest in research & development by offering customized solutions in terms of facility sizes and products used for the construction. Europe is projected to deliver a high rate as the region is registering a higher number of patients. The growing focus on introducing flexible but robust medical research laboratories will be helpful in Europe’s overall growth. The most common types of contagious medical conditions in the region include tuberculosis, salmonellas, campylobacteriosis, chlamydia infection, and gonorrhea.
The global mobile biosafety laboratory market is led by players like:
By Application
By Type
FrequentlyAsked Questions
A mobile biosafety laboratory is a facility equipped to manage the collection, analysis, and research of biological samples across locations, especially in remote areas or regions that are not easily accessible.
The global mobile biosafety laboratory market is expected to grow due to the increasing number of cases of infectious and contagious diseases across the globe.
According to study, the global mobile biosafety laboratory market size was worth around USD 235.16 million in 2023 and is predicted to grow to around USD 450.86 million by 2032.
The CAGR value of mobile biosafety laboratory market is expected to be around 7.50% during 2024-2032.
The global mobile biosafety laboratory market will be dominated by North America during the forecast period.
The global mobile biosafety laboratory market is led by players like Mesa Labs, Bluestar BioTech, Microchem Laboratory, Bioneer, SanAir Technologies Laboratory, Hardy Diagnostics, IQuaTest, BiolabTech, Labconco, BSL Biosafety, Innohome, bioMérieux, BSL-3 Laboratory Solutions, MycoTech and Containment Solutions, Inc.
The report explores crucial aspects of the mobile biosafety laboratory market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed